Correction of Mucopolysaccharidosis Type I (MPS I) with Multipotent Adult Progenitor Cells (MAPCs) in an Immunodeficient Mouse Model
2010-04-21
Loading...
View/Download File
Persistent link to this item
Statistics
View StatisticsJournal Title
Journal ISSN
Volume Title
Title
Correction of Mucopolysaccharidosis Type I (MPS I) with Multipotent Adult Progenitor Cells (MAPCs) in an Immunodeficient Mouse Model
Authors
Published Date
2010-04-21
Publisher
Type
Presentation
Abstract
Hurler Syndrome or Mucopolysaccharidosis I (MPS I) is an autosomal recessive lysosomal storage
disease characterized by skeletal abnormalities, hepatosplenomegaly, and neurological degeneration.
Children who exhibit MPS I lack α-L-iduronidase (IDUA), a crucial enzyme in the degradation pathway
of glycosaminoglycans (GAGs), specifically heparan and dermatan sulfate. GAG accumulation in
lysosomes interferes with normal cell function creating multi-systemic problems. Current treatments
including enzyme replacement therapy and hematopoietic stem cell transplantation are not widely
available and fail to correct the majority of symptoms, particularly mental retardation and skeletal
anomalies. Using a NOD/SCID immunodeficient mouse model of MPS I, we attempted to correct the
enzyme deficiency by transplanting human multipotent adult progenitor cells (MAPCs) directly into the
striatum within five days of birth. Through the process of cross-correction, the IDUA enzyme released
from the transplanted cells is taken up by the defective cells. The efficacy of the MAPCs was
investigated through measurement of IDUA levels in different tissues, immunohistochemical staining,
and sensorimotor testing. The transplanted MAPCs were detected throughout the central nervous
system along with decreased levels of GAGs indicating sufficient delivery of IDUA to the cells.
Sensorimotor coordination on a rotarod test improved in the MAPC-treated MPS I mice compared to
untreated MPS I mice. These results denote that transplantation of MAPCs into the striatum greatly
reduces GAG tissue levels in the brain and ameliorates sensorimotor function in MPS I mice.
Description
Additional contributors: Zhenhong Nan; Laurie Shekel; Matthew S. Nelson; Shaukat A. Kahn; Oleg Ryabinin; Pankaj Gupta; Walter C. Low (faculty mentor).
Related to
Replaces
License
Series/Report Number
Funding information
Isbn identifier
Doi identifier
Previously Published Citation
Suggested citation
Evavold, Carrie. (2010). Correction of Mucopolysaccharidosis Type I (MPS I) with Multipotent Adult Progenitor Cells (MAPCs) in an Immunodeficient Mouse Model. Retrieved from the University Digital Conservancy, https://hdl.handle.net/11299/61838.
Content distributed via the University Digital Conservancy may be subject to additional license and use restrictions applied by the depositor. By using these files, users agree to the Terms of Use. Materials in the UDC may contain content that is disturbing and/or harmful. For more information, please see our statement on harmful content in digital repositories.